From Genome to Therapy: Industry Perspective

  1. Gregory R. Bock,
  2. Dalia Cohen,
  3. Jamie A. Goode
  1. Paul L. Herrling

Published Online: 29 APR 2008

DOI: 10.1002/047084664X.ch18

Book Title

From Genome to Therapy: Novartis Foundation Symposium 229

From Genome to Therapy: Novartis Foundation Symposium 229

Additional Information

How to Cite

Herrling, P. L. (2008) From Genome to Therapy: Industry Perspective, in From Genome to Therapy: Novartis Foundation Symposium 229 (eds G. R. Bock, D. Cohen and J. A. Goode), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/047084664X.ch18

Author Information

  1. Novartis Pharma AG, Basel, Switzerland

Publication History

  1. Published Online: 29 APR 2008
  2. Published Print: 26 SEP 2000

Book Series:

  1. Novartis Foundation Symposia

Book Series Editors:

  1. Novartis Foundation

ISBN Information

Print ISBN: 9780471627449

Online ISBN: 9780470846643

SEARCH

CHAPTER TOOLS

Get PDF (240K)

Keywords:

  • pharmaceutical;
  • industry;
  • drug;
  • therapy;
  • genomics;
  • functional genomics;
  • Novartis;
  • proteomics
Get PDF (240K)